CEZYY yields 18.44% · JNJ yields 2.13%● Live data
📍 CEZYY pulled ahead of the other in Year 1
Combined, CEZYY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CEZYY + JNJ for your $10,000?
CEZ, a. s., an electricity generation company, engages in the production, distribution, trade, and sale of electricity and heat in Western, Central, and Southeastern Europe. The company operates through four segments: Generation, Distribution, Sales, and Mining. It operates two nuclear plants, sixteen hydroelectric plants, one combined cycle gas turbine plant, and eight fossil fuel plants in the Czech Republic. The company also operates various fossil fuel, hydro, wind, solar, gas, biogas, and biomass power plants in the Czech Republic; eleven wind power plants in Germany; and two fossil fuel plants and two hydroelectric plants in Poland. In addition, it is involved in the trade and sale of natural gas; mining of coal; quarrying and processing of construction aggregates and limestones; commodity trading business; and provision of energy services. Further, the company holds interest in the lithium ore mining project in Cínovec. CEZ, a. s. was incorporated in 1992 and is headquartered in Prague, the Czech Republic.
Full CEZYY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.